Status:
UNKNOWN
Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
National IT Industry Promotion Agency
Conditions:
Gastric Cancer
Eligibility:
All Genders
19-75 years
Phase:
NA
Brief Summary
Recently, the use of mobile health is increasing for the purpose of managing prognosis such as recurrence, survival and quality of life by using a wearable smart band together with a smartphone applic...
Eligibility Criteria
Inclusion
- AJCC stage I-III who has undergone radical gastric cancer surgery (chemotherapy, radiation therapy is irrelevant)
- Patients aged 19 to 75 years old
- Those who can use prognosis management applications and can perform regular follow-up inspections outpatients
- Patients carrying Android or iOS smartphones
- Patients who voluntarily decide to participate and give written consent after hearing detailed explanations about this study
Exclusion
- Those who have difficulty using gastric cancer applications (exercise performance, diet management, etc.) due to severe underlying diseases, neuromusculoskeletal diseases, cognitive, and visual impairments
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT04907591
Start Date
May 17 2021
End Date
May 30 2024
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Anam Hospital
Seoul, Seongbuk-gu, South Korea, 02841